-
Something wrong with this record ?
High-cholesterol diet in combination with hydroxypropyl-beta-cyclodextrin induces NASH-like disorders in the liver of rats
Y. Saigo, T. Sasase, M. Tohma, K. Uno, Y. Shinozaki, T. Maekawa, R. Sano, K. Miyajima, T. Ohta
Language English Country Czech Republic
Document type Journal Article
NLK
Directory of Open Access Journals
from 1991
Free Medical Journals
from 1998
PubMed Central
from 2020
ProQuest Central
from 2005-01-01
Medline Complete (EBSCOhost)
from 2006-01-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 1998
PubMed
37449749
Knihovny.cz E-resources
- MeSH
- Cholesterol MeSH
- Diet, High-Fat adverse effects MeSH
- 2-Hydroxypropyl-beta-cyclodextrin metabolism therapeutic use MeSH
- Hypercholesterolemia * metabolism MeSH
- Hyperlipidemias * MeSH
- Liver metabolism MeSH
- Rats MeSH
- Humans MeSH
- Disease Models, Animal MeSH
- Non-alcoholic Fatty Liver Disease * chemically induced MeSH
- Rats, Sprague-Dawley MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Humans MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Non-alcoholic fatty liver disease (NAFLD) is a general term for fatty liver disease not caused by viruses or alcohol. Fibrotic hepatitis, cirrhosis, and hepatocellular carcinoma can develop. The recent increase in NAFLD incidence worldwide has stimulated drug development efforts. However, there is still no approved treatment. This may be due in part to the fact that non-alcoholic steatohepatitis (NASH) pathogenesis is very complex, and its mechanisms are not well understood. Studies with animals are very important for understanding the pathogenesis. Due to the close association between the establishment of human NASH pathology and metabolic syndrome, several animal models have been reported, especially in the context of overnutrition. In this study, we investigated the induction of NASH-like pathology by enhancing cholesterol absorption through treatment with hydroxypropyl-beta-cyclodextrin (CDX). Female Sprague-Dawley rats were fed a normal diet with normal water (control group); a high-fat (60 kcal%), cholesterol (1.25 %), and cholic acid (0.5 %) diet with normal water (HFCC group); or HFCC diet with 2 % CDX water (HFCC+CDX group) for 16 weeks. Compared to the control group, the HFCC and HFCC+CDX groups showed increased blood levels of total cholesterol, aspartate aminotransferase, and alanine aminotransferase. At autopsy, parameters related to hepatic lipid synthesis, oxidative stress, inflammation, and fibrosis were elevated, suggesting the development of NAFLD/NASH. Elevated levels of endoplasmic reticulum stress-related genes were evident in the HFCC+CDX group. In the novel rat model, excessive cholesterol intake and accelerated absorption contributed to NAFLD/NASH pathogenesis.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23012415
- 003
- CZ-PrNML
- 005
- 20230823152048.0
- 007
- ta
- 008
- 230804s2023 xr da f 000 0|eng||
- 009
- AR
- 024 7_
- $2 doi $a 10.33549/physiolres.934981
- 035 __
- $a (PubMed)37449749
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Saigo, Yasuka $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan $u Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
- 245 10
- $a High-cholesterol diet in combination with hydroxypropyl-beta-cyclodextrin induces NASH-like disorders in the liver of rats / $c Y. Saigo, T. Sasase, M. Tohma, K. Uno, Y. Shinozaki, T. Maekawa, R. Sano, K. Miyajima, T. Ohta
- 520 9_
- $a Non-alcoholic fatty liver disease (NAFLD) is a general term for fatty liver disease not caused by viruses or alcohol. Fibrotic hepatitis, cirrhosis, and hepatocellular carcinoma can develop. The recent increase in NAFLD incidence worldwide has stimulated drug development efforts. However, there is still no approved treatment. This may be due in part to the fact that non-alcoholic steatohepatitis (NASH) pathogenesis is very complex, and its mechanisms are not well understood. Studies with animals are very important for understanding the pathogenesis. Due to the close association between the establishment of human NASH pathology and metabolic syndrome, several animal models have been reported, especially in the context of overnutrition. In this study, we investigated the induction of NASH-like pathology by enhancing cholesterol absorption through treatment with hydroxypropyl-beta-cyclodextrin (CDX). Female Sprague-Dawley rats were fed a normal diet with normal water (control group); a high-fat (60 kcal%), cholesterol (1.25 %), and cholic acid (0.5 %) diet with normal water (HFCC group); or HFCC diet with 2 % CDX water (HFCC+CDX group) for 16 weeks. Compared to the control group, the HFCC and HFCC+CDX groups showed increased blood levels of total cholesterol, aspartate aminotransferase, and alanine aminotransferase. At autopsy, parameters related to hepatic lipid synthesis, oxidative stress, inflammation, and fibrosis were elevated, suggesting the development of NAFLD/NASH. Elevated levels of endoplasmic reticulum stress-related genes were evident in the HFCC+CDX group. In the novel rat model, excessive cholesterol intake and accelerated absorption contributed to NAFLD/NASH pathogenesis.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a nealkoholová steatóza jater $x chemicky indukované $7 D065626
- 650 _2
- $a hydroxypropyl beta cyklodextrin $x metabolismus $x terapeutické užití $7 D000073738
- 650 _2
- $a potkani Sprague-Dawley $7 D017207
- 650 _2
- $a dieta s vysokým obsahem tuků $x škodlivé účinky $7 D059305
- 650 _2
- $a játra $x metabolismus $7 D008099
- 650 _2
- $a cholesterol $7 D002784
- 650 12
- $a hypercholesterolemie $x metabolismus $7 D006937
- 650 12
- $a hyperlipidemie $7 D006949
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sasase, Tomohiko $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan $u Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
- 700 1_
- $a Tohma, Marika $u Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, Tokyo, Japan
- 700 1_
- $a Uno, Kinuko $u Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, Tokyo, Japan
- 700 1_
- $a Shinozaki, Yuichi $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan $u Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
- 700 1_
- $a Maekawa, Tatsuya $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan
- 700 1_
- $a Sano, Ryuhei $u Biological/Pharmacological Research Laboratories, Takatsuki Research Center, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan $u Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, Tokyo, Japa
- 700 1_
- $a Miyajima, Katsuhiro $u Department of Nutritional Science and Food Safety, Faculty of Applied Biosciences, Tokyo University of Agriculture, Tokyo, Japan
- 700 1_
- $a Ohta, Takeshi $u Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 72, č. 3 (2023), s. 371-382
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37449749 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20230804 $b ABA008
- 991 __
- $a 20230823152046 $b ABA008
- 999 __
- $a ok $b bmc $g 1972834 $s 1198684
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 72 $c 3 $d 371-382 $e 2023Jul14 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK198 $a Pubmed-20230804